(firstQuint)Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation.

 Lymphoma patients with anemia on day +15 post-transplant will be randomized to erythropoietin group or control group.

 Potential benefit of erythropoietin will be evaluatedon day +60 post-transplant.

.

 Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation@highlight

This is an randomized trial to evaluate the potential benefit of erythropoietin in the treatment of anemia in patients with lymphoma after autologous hematopoietic stem cell transplantation.

